Table 5 Characteristics of the SSc patients with clinical and subclinical myocardial involvement
Clinical involvement(n = 14) | Subclinical involvement(n = 7) | P | |
|---|---|---|---|
Immunological characteristics | |||
Elevated ESR | 2 (14.3) | 4 (57.1) | 0.120 |
Elevated CTnI | 11 (78.6) | 3/5 (60) | 0.570 |
Elevated NT-proBNP | 11 (78.6) | 6 (85.7) | 1.000 |
UCG and ECG abnormalities | |||
Ventricular arrhythmia | 3 (21.4) | 1 (14.3) | 1.000 |
Supraventricular arrhythmia | 1 (7.1) | 1 (14.3) | 1.000 |
Atrioventricular block | 2 (14.3) | 0 (0) | 0.533 |
Atrial fibrillation | 1 (7.1) | 0 (0) | 1.000 |
RV systolic dysfunction | 5 (35.7) | 1 (14.3) | 0.613 |
LV diastolic dysfunction | 4 (28.6) | 2 (28.6) | 1.000 |
LVEF < 50% | 6 (42.9) | 4 (57.1) | 0.659 |
Pericardial effusion | 7 (50) | 2 (28.6) | 0.642 |
CMR abnormalities | |||
LGE positivity | 8/10 (80) | 4/5 (80) | 1.000 |